RYLGX
Price
$114.43
Change
-$2.48 (-2.12%)
Updated
Feb 3 closing price
Net Assets
34.03M
VIGRX
Price
$243.70
Change
-$6.76 (-2.70%)
Updated
Feb 3 closing price
Net Assets
352.38B
Interact to see
Advertisement

RYLGX vs VIGRX

Header iconRYLGX vs VIGRX Comparison
Open Charts RYLGX vs VIGRXBanner chart's image
Rydex S&P 500 Pure Growth A
Price$114.43
Change-$2.48 (-2.12%)
VolumeN/A
Net Assets34.03M
Vanguard Growth Index Investor
Price$243.70
Change-$6.76 (-2.70%)
VolumeN/A
Net Assets352.38B
RYLGX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
RYLGX vs. VIGRX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLGX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 352B vs. RYLGX (34M). VIGRX pays higher dividends than RYLGX: VIGRX (0.30) vs RYLGX (0.00). RYLGX was incepted earlier than VIGRX: RYLGX (21 years) vs VIGRX (33 years). RYLGX (1.59) is less costly to investors than VIGRX (0.17). RYLGX is a more actively managed with annual turnover of: 1148.00 vs. VIGRX (11.00). RYLGX has a lower initial minimum investment than VIGRX: RYLGX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 14.30 vs. RYLGX (7.92). VIGRX return over 5 years is better than : 79.50 vs. RYLGX (31.56).
RYLGXVIGRXRYLGX / VIGRX
Total Expense Ratio1.540.17906%
Annual Report Gross Expense Ratio1.590.17935%
Fund Existence21 years33 years-
Gain YTD5.320-2.997-177%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets34M352B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year7.9214.3055%
Returns for 3 years48.6394.6551%
Returns for 5 years31.5679.5040%
Returns for 10 years149.36395.6538%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLTE187.2713.96
+8.05%
Belite Bio
ALDF10.58-0.01
-0.09%
Aldel Finl II INC
ANEB0.95-0.01
-0.75%
Anebulo Pharmaceuticals
MA550.72-4.65
-0.84%
Mastercard
NSP40.05-3.10
-7.18%
Insperity